v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Total revenues $ 3,160,185 $ 3,321,485
Cost of revenues 1,962,074 1,461,514
Gross margin 1,198,111 1,859,971
Operating expenses    
Compensation and related benefits 1,732,003 1,658,998
General and administrative 2,440,383 2,032,291
Total operating expenses 4,172,386 3,691,289
Net operating loss (2,974,275) (1,831,318)
Other income (expense)    
Interest expense (113,098) (730,665)
Other income, net 0 15,539
Change in fair value of financial instruments 143,040 (1,261,471)
Gain on extinguishment of financial liabilities 367,809 0
Loss on issuance of financial instruments 0 (138,020)
Total other income (expense), net 397,751 (2,114,617)
Loss before provision for income taxes (2,576,524) (3,945,935)
   
Provision for income taxes (23,738) (13,505)
Net loss $ (2,600,262) $ (3,959,440)
Basic loss per common share (in Dollars per share) $ (0.05) $ (0.24)
Diluted loss per common share (in Dollars per share) $ (0.05) $ (0.24)
Weighted average number of common shares outstanding, basic (in Shares) 47,902,512 16,312,468
Weighted average number of common shares outstanding, diluted (in Shares) 47,902,512 16,312,468
Subscription fees    
Revenues    
Total revenues $ 605,470 $ 827,345
Professional services and other fees    
Revenues    
Total revenues 580,981 896,680
Technical engineering fees    
Revenues    
Total revenues 94,441 399,846
Patient fees    
Revenues    
Total revenues 881,340 711,264
Telehealth fees    
Revenues    
Total revenues 997,953 483,850
Institutional fees    
Revenues    
Total revenues $ 0 $ 2,500